Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Atlas Venture Associates IX, LLC

Q4 2021 · 13F-HR

Atlas Venture Associates IX, LLCholdings as filed

Filed 2022-01-27 · accession 0001104659-22-007928

$229,102
Reported value
7
Positions
2021-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
83067L109SKILLZ INC$170,44974.4%22,909,859CommonSOLE
84833T103SPROSPERO THERAPEUTICS INC$22,0459.62%1,376,968CommonSOLE
86877M209SURFACE ONCOLOGY INC$14,0796.15%2,945,453CommonSOLE
19240Q201COGTCOGENT BIOSCIENCES INC$7,8663.43%916,832CommonSOLE
83304A106SNAPSNAP INC$7,0633.08%150,160CommonNONE
87166L100SYNLOGIC INC$6,4182.80%2,651,963CommonSOLE
45826J105NTLAINTELLIA THERAPEUTICS INC$1,1820.52%10,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.